086900 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and antitoxin therapeutics. The company was founded on May 2, 2000 and is headquartered in Cheongwon-gun, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
086900 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company